Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Net Margin (2017 - 2025)

Historic Net Margin for Lexaria Bioscience (LEXX) over the last 12 years, with Q3 2025 value amounting to 1551.72%.

  • Lexaria Bioscience's Net Margin fell 10673200.0% to 1551.72% in Q3 2025 from the same period last year, while for Nov 2025 it was 2068.97%, marking a year-over-year increase of 5999300.0%. This contributed to the annual value of 1685.74% for FY2025, which is 4364800.0% up from last year.
  • Per Lexaria Bioscience's latest filing, its Net Margin stood at 1551.72% for Q3 2025, which was down 10673200.0% from 2183.91% recorded in Q2 2025.
  • Lexaria Bioscience's 5-year Net Margin high stood at 6491.89% for Q1 2023, and its period low was 14359.92% during Q4 2021.
  • For the 5-year period, Lexaria Bioscience's Net Margin averaged around 767.51%, with its median value being 1551.72% (2025).
  • In the last 5 years, Lexaria Bioscience's Net Margin crashed by -141245000bps in 2021 and then skyrocketed by 162016400bps in 2022.
  • Quarter analysis of 5 years shows Lexaria Bioscience's Net Margin stood at 14359.92% in 2021, then skyrocketed by 113bps to 1841.71% in 2022, then crashed by -57bps to 793.24% in 2023, then surged by 85bps to 1468.01% in 2024, then increased by 6bps to 1551.72% in 2025.
  • Its Net Margin stands at 1551.72% for Q3 2025, versus 2183.91% for Q2 2025 and 1551.72% for Q1 2025.